Blackrock Science And Stock Fundamentals
| BSTZ Stock | USD 21.21 0.06 0.28% |
By evaluating key metrics such as revenue growth, profitability, cash flow trends, and balance sheet strength, investors can better assess BlackRock Science's long-term financial health and intrinsic value.
At this time, BlackRock Science's Selling General Administrative is fairly stable compared to the past year. Research Development is likely to rise to 7.35 in 2025, despite the fact that Depreciation And Amortization is likely to grow to (357.5 K). BlackRock | Select Account or Indicator | Build AI portfolio with BlackRock Stock |
BlackRock Science and Company Number Of Shares Shorted Analysis
BlackRock Science's Number of Shares Shorted is the total amount of shares that are currently sold short by investors. When a stock is sold short, the short seller assumes the responsibility of repurchasing the stock at a lower price. The speculator will make money if the stock goes down in price or will experience a loss if the stock price goes up.
More About Number Of Shares Shorted | All Equity Analysis
Shares Shorted | = | Shorted by Public | + | by Institutions |
Current BlackRock Science Number Of Shares Shorted | 174.66 K |
Most of BlackRock Science's fundamental indicators, such as Number Of Shares Shorted, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, BlackRock Science and is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
If a large number of investors decide to short sell an equity instrument within a small period of time, their combined action can significantly affect the price of the stock.
| Competition |
Based on the recorded statements, BlackRock Science and has 174.66 K of outstending shares currently sold short by investors. This is 96.97% lower than that of the Capital Markets sector and 96.71% lower than that of the Financials industry. The number of shares shorted for all United States stocks is 96.29% higher than that of the company.
BlackRock Science Fundamental Drivers Relationships
Comparative valuation techniques use various fundamental indicators to help in determining BlackRock Science's current stock value. Our valuation model uses many indicators to compare BlackRock Science value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across BlackRock Science competition to find correlations between indicators driving BlackRock Science's intrinsic value. More Info.BlackRock Science and is number one stock in shares outstanding category among its peers. It also is number one stock in shares owned by insiders category among its peers . The ratio of Shares Outstanding to Shares Owned By Insiders for BlackRock Science and is about 6,409,709,091 . The reason why the comparable model can be used in almost all circumstances is due to the vast number of multiples that can be utilized, such as the price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S), price-to-cash flow (P/CF), and many others. The P/E ratio is the most commonly used of these ratios because it focuses on the BlackRock Science's earnings, one of the primary drivers of an investment's value.BlackRock Number Of Shares Shorted Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses BlackRock Science's direct or indirect competition against its Number Of Shares Shorted to detect undervalued stocks with similar characteristics or determine the stocks which would be a good addition to a portfolio. Peer analysis of BlackRock Science could also be used in its relative valuation, which is a method of valuing BlackRock Science by comparing valuation metrics of similar companies.BlackRock Science is currently under evaluation in number of shares shorted category among its peers.
BlackRock Science Current Valuation Drivers
We derive many important indicators used in calculating different scores of BlackRock Science from analyzing BlackRock Science's financial statements. These drivers represent accounts that assess BlackRock Science's ability to generate profits relative to its revenue, operating costs, and shareholders' equity. Below are some of BlackRock Science's important valuation drivers and their relationship over time.
| 2020 | 2021 | 2022 | 2023 | 2024 | 2025 (projected) | ||
| Market Cap | 1.4B | 1.6B | 915.5M | 1.1B | 1.3B | 943.4M | |
| Enterprise Value | 1.4B | 1.6B | 915.5M | 1.1B | 1.3B | 944.1M |
BlackRock Fundamentals
| Shares Outstanding | 70.51 M | ||||
| Shares Owned By Insiders | 0.01 % | ||||
| Shares Owned By Institutions | 28.19 % | ||||
| Number Of Shares Shorted | 174.66 K | ||||
| Price To Earning | 5.56 X | ||||
| Price To Book | 0.89 X | ||||
| Price To Sales | 5.59 X | ||||
| Revenue | 274.17 M | ||||
| EBITDA | 277.81 M | ||||
| Net Income | 277.54 M | ||||
| Total Debt | 6.03 M | ||||
| Cash Flow From Operations | 231.7 M | ||||
| Short Ratio | 0.81 X | ||||
| Earnings Per Share | 7.86 X | ||||
| Market Capitalization | 1.5 B | ||||
| Total Asset | 774.59 M | ||||
| Retained Earnings | (173.53 M) | ||||
| Annual Yield | 0.12 % | ||||
| Net Asset | 774.59 M |
About BlackRock Science Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze BlackRock Science and's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of BlackRock Science using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of BlackRock Science and based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.| Last Reported | Projected for Next Year | ||
| Total Revenue | 274.2 M | 143.1 M | |
| Cost Of Revenue | 23.5 M | 27.2 M | |
| Revenue Per Share | 7.91 | 8.31 | |
| Ebit Per Revenue | 0.99 | 0.94 |
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.Additional Tools for BlackRock Stock Analysis
When running BlackRock Science's price analysis, check to measure BlackRock Science's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy BlackRock Science is operating at the current time. Most of BlackRock Science's value examination focuses on studying past and present price action to predict the probability of BlackRock Science's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move BlackRock Science's price. Additionally, you may evaluate how the addition of BlackRock Science to your portfolios can decrease your overall portfolio volatility.